Erratum: Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Treatment and Pharmacology
Due to a production error, the article type of this article mislabeled as Clinical Trial. The correct article type is Study Protocol.
The publisher apologizes for this mistake.
The original version of this article has been updated.
The publisher apologizes for this mistake. The original version of this article has been updated.
